Could muscle loss predict stroke recovery?

NCT ID NCT07764172

Recruiting now Knowledge-focused Sponsor: University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study investigates whether sarcopenia—age-related muscle loss—is common in older adults during the acute phase of ischemic stroke and whether it influences recovery. Researchers will assess muscle mass and function in 400 patients aged 50 and older within 72 hours of stroke onset, then track their functional outcomes at 14 and 90 days. The goal is to understand if early muscle loss is linked to worse disability, complications, or mortality, which could inform future rehabilitation strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If muscle loss is found to predict worse recovery, this could lead to early screening and targeted rehabilitation to improve stroke outcomes.
What could go wrong: This is an observational study, so it cannot prove cause and effect. Results may not apply to all stroke patients, and the follow-up period is limited to three months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke Sarcopenia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE STROKE SARCOPENIA

Contacts and locations

Locations

Moscow State Budgetary Healthcare Institution "Moscow City Hospital named after S.S. Yudin, Moscow Healthcare Department"
RECRUITING

Moscow, 115446, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.